Metformin sensitizes insulin signaling through AMPK-mediated pten down-regulation in preadipocyte 3T3-L1 cells

Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus

(2009) Adriaan Kooy et al.   ARCHIVES OF INTERNAL MEDICINE

Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein

(2009) Ling He et al.   CELL

Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats

(2009) Taishi Yoshida et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Important role of the LKB1–AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice

(2008) Xu Huang et al.   BIOCHEMICAL JOURNAL

Metformin: Effects on Micro and Macrovascular Complications in Type 2 Diabetes

(2008) Clifford J. Bailey   CARDIOVASCULAR DRUGS AND THERAPY

PTEN as a Unique Promising Therapeutic Target for Occupational Asthma

(2008) So Ri Kim et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels

(2008) Andrea Anedda et al.   JOURNAL OF ENDOCRINOLOGY

PTEN Down-Regulation by Unsaturated Fatty Acids Triggers Hepatic Steatosis via an NF-κBp65/mTOR-Dependent Mechanism

(2007) Manlio Vinciguerra et al.   GASTROENTEROLOGY